Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring
2005

Monitoring Breast Cancer Treatment with Blood Tests

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Pachmann Katharina, Camara Oumar, Kavallaris Andreas, Schneider Uwe, Schünemann Stefanie, Höffken Klaus

Primary Institution: Klinik für Innere Medizin II der Friedrich Schiller-Universität Jena

Hypothesis

Can circulating epithelial cells be used to monitor the effectiveness of neoadjuvant therapy in breast cancer patients?

Conclusion

The response of circulating epithelial cells reflects the overall tumor response to therapy, suggesting they can be used for monitoring treatment effectiveness.

Supporting Evidence

  • Circulating epithelial cells were detected in all breast cancer patients before therapy.
  • The reduction in circulating tumor cells was strongly correlated with final tumor reduction in patients receiving chemotherapy.
  • The method allows for real-time monitoring of therapy effectiveness.

Takeaway

Doctors can check how well breast cancer treatment is working by looking at special cells in the blood. If these cells go down, it usually means the tumor is getting smaller.

Methodology

MAINTRAC® analysis was used to monitor circulating epithelial cells in blood samples from breast cancer patients during neoadjuvant chemotherapy.

Limitations

The study only analyzed the first few cycles of chemotherapy, and results may not apply to later cycles or different treatment regimens.

Participant Demographics

30 breast cancer patients undergoing neoadjuvant chemotherapy.

Digital Object Identifier (DOI)

10.1186/bcr1328

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication